International Journal of Molecular Zoology 2024, Vol.14, No.4, 244-254 http://animalscipublisher.com/index.php/ijmz 251 7.2 Potential off-target effects and genetic stability The use of CRISPR-Cas9 and other gene-editing technologies to create genetically modified pigs introduces the risk of off-target effects, which can lead to unintended genetic alterations. These off-target effects can compromise the genetic stability of the modified pigs, potentially leading to unforeseen health issues or reduced viability of the xenografts (Sykes and Sachs, 2019). Ensuring the precision and accuracy of genetic modifications is crucial, as even minor off-target effects can have significant implications for the safety and efficacy of xenotransplantation (Kemter et al., 2020). Continuous monitoring and validation of the genetic modifications are necessary to mitigate these risks and ensure the long-term stability of the engineered pigs (Yue et al., 2020). 7.3 Long-term health and viability of genetically modified pigs The long-term health and viability of genetically modified pigs are critical factors for the success of xenotransplantation. While initial studies have shown that genetically engineered pigs can exhibit normal physiology, fertility, and germline transmission of edited genes, the long-term effects of extensive genetic modifications are still not fully understood (Yue et al., 2020; Lei et al., 2022). There is a need for comprehensive longitudinal studies to assess the health, reproductive capabilities, and overall viability of these pigs over their lifespan. Additionally, the potential impact of genetic modifications on the pigs' immune system and their ability to resist infections must be thoroughly investigated to ensure the sustainability of xenotransplantation efforts (Wolf et al., 2019). 8 Future Directions and Perspectives 8.1 Emerging trends and innovations in genetic engineering for xenotransplantation Recent advancements in genetic engineering have significantly enhanced the potential of xenotransplantation. The use of CRISPR-Cas9 and transposon technologies has enabled the production of pigs with inactivated porcine endogenous retroviruses (PERVs) and the introduction of human transgenes to improve immunological compatibility and blood-coagulation compatibility with humans (Yue et al., 2020). Additionally, the development of pigs with multiple genetic modifications, such as the deletion of pig-specific antigens and the insertion of human complement and coagulation-regulatory transgenes, has shown promise in overcoming immune rejection and physiological incompatibilities (Wolf et al., 2019; Lei et al., 2022). These innovations are paving the way for safer and more effective xenotransplantation practices. 8.2 Potential breakthroughs and future vision for pathogen-free pigs The creation of pathogen-free pigs is a critical goal for the future of xenotransplantation. Advances in genome editing have allowed for the inactivation of PERVs, which are integrated into the pig genome and pose a risk of cross-species transmission (Denner, 2022). Furthermore, the development of highly sensitive diagnostic methods for detecting xenotransplantation-relevant viruses, such as porcine cytomegalovirus (PCMV) and porcine circovirus 3 (PCV3), is essential for ensuring the safety of xenotransplant recipients (Hartline et al., 2018). Future research should focus on refining these techniques and exploring additional genetic modifications to eliminate other potential zoonotic pathogens, thereby creating a safer and more reliable source of organs for transplantation (Karuppannan and Opriessnig, 2018). 8.3 Collaborative and interdisciplinary research opportunities The complexity of xenotransplantation necessitates a collaborative and interdisciplinary approach. Researchers from fields such as genetics, immunology, virology, and bioethics must work together to address the various challenges associated with xenotransplantation. For instance, the ethical considerations of using genetically modified pigs for organ transplantation require input from bioethicists to ensure that the benefits outweigh the potential harms (Cengiz and Wareham, 2019). Additionally, collaboration between virologists and genetic engineers is crucial for developing strategies to eliminate or mitigate the risks of cross-species virus transmission (Karuppannan and Opriessnig, 2018; Denner, 2022). By fostering interdisciplinary research, the scientific community can accelerate the development of safe and effective xenotransplantation practices.
RkJQdWJsaXNoZXIy MjQ4ODYzNA==